Kodiak Sciences Inc. SEC filings KOD
Kodiak Sciences Inc. has 422 filings in SEC EDGAR's recent list, going back to Jul 28, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Mar 31, 2026 | — |
| 424B5 | Prospectus supplement | Dec 17, 2025 | — |
| 424B5 | Prospectus supplement | Dec 15, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| S-3 | Shelf registration | May 15, 2023 | — |
| S-3 | Shelf registration | Mar 31, 2023 | — |
| S-8 | Employee stock plan registration | Mar 28, 2023 | — |
| S-8 | Employee stock plan registration | May 10, 2022 | — |
| S-8 | Employee stock plan registration | Dec 15, 2021 | — |
| S-3ASR | Automatic shelf registration | May 10, 2021 | — |
| S-8 | Employee stock plan registration | Mar 2, 2021 | — |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| 424B5 | Prospectus supplement | Nov 16, 2020 | — |
| S-3ASR | Automatic shelf registration | Nov 16, 2020 | — |
| 424B3 | Prospectus | Dec 4, 2019 | — |
| 424B3 | Prospectus | Dec 3, 2019 | — |
| S-3 | Shelf registration | Nov 1, 2019 | — |
| S-8 | Employee stock plan registration | May 15, 2019 | — |
| S-8 | Employee stock plan registration | Oct 9, 2018 | — |
| 424B4 | Prospectus | Oct 5, 2018 | — |
| FWP | Free writing prospectus | Oct 4, 2018 | — |
| S-1/A | Amended registration statement | Oct 1, 2018 | — |
| S-1/A | Amended registration statement | Sep 24, 2018 | — |
| S-1/A | Amended registration statement | Sep 11, 2018 | — |
| S-1 | Registration statement | Sep 7, 2018 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KOD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1468748
- Former names
- Oligasis, LLC (until Jul 28, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.